{
    "organizations": [],
    "uuid": "383ca039af5c4a11d47f548c171fa09bf488ebbf",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-dicerna-pharmaceuticals-q1-loss-pe/brief-dicerna-pharmaceuticals-q1-loss-per-share-0-30-idUSASC0A221",
    "ord_in_thread": 0,
    "title": "BRIEF-Dicerna Pharmaceuticals Q1 Loss Per Share $0.30",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 14 (Reuters) - Dicerna Pharmaceuticals Inc:\n* DICERNA REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS AND PROVIDES CORPORATE UPDATE\n* DICERNA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.30\n* DICERNA PHARMACEUTICALS INC - BELIEVES THAT IT HAS SUFFICIENT CASH TO FUND EXECUTION OF ITS CURRENT CLINICAL AND OPERATING PLAN THROUGH 2019\n* DICERNA PHARMACEUTICALS INC - FOR THREE-MONTH PERIOD ENDED MARCH 31, 2018, DICERNA RECOGNIZED $1.5 MILLION OF REVENUE ASSOCIATED WITH BI AGREEMENT Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Reuters Plus Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\nÂ© 2018 Reuters. All Rights Reserved.",
    "published": "2018-05-15T04:13:00.000+03:00",
    "crawled": "2018-05-15T14:01:24.023+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "dicerna",
        "pharmaceutical",
        "inc",
        "dicerna",
        "report",
        "first",
        "quarter",
        "financial",
        "operating",
        "result",
        "provides",
        "corporate",
        "update",
        "dicerna",
        "pharmaceutical",
        "inc",
        "qtrly",
        "loss",
        "per",
        "share",
        "dicerna",
        "pharmaceutical",
        "inc",
        "belief",
        "sufficient",
        "cash",
        "fund",
        "execution",
        "current",
        "clinical",
        "operating",
        "plan",
        "dicerna",
        "pharmaceutical",
        "inc",
        "period",
        "ended",
        "march",
        "dicerna",
        "recognized",
        "million",
        "revenue",
        "associated",
        "bi",
        "agreement",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle",
        "apps",
        "newsletter",
        "reuters",
        "plus",
        "advertising",
        "guideline",
        "cooky",
        "term",
        "use",
        "privacy",
        "quote",
        "delayed",
        "minimum",
        "minute",
        "see",
        "complete",
        "list",
        "exchange",
        "delay",
        "reuters",
        "right",
        "reserved"
    ]
}